Indications
Therapeutic Asset Ratings
9,922 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
lp-118
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Wake Forest University Health Sciences
P1
CC
(43)
lp-118
Richter Transformation
Newave Pharmaceutical Inc
P1
CC
(43)
lp-118
T-Cell Prolymphocytic Leukemia
Newave Pharmaceutical Inc
P1
CC
(43)
lp-168
Hairy Cell Leukemia
Newave Pharmaceutical Inc
P1
CC
(43)
LP284
Lymphoma
Lantern Pharma Inc.
P1
CC
(43)
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)-
Glioma
Barbara Ann Karmanos Cancer Institute
P1
CC
(43)
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)-
Metastatic Malignant Neoplasm In The Brain
Barbara Ann Karmanos Cancer Institute
P1
CC
(43)
Ltz-301
Follicular Lymphoma
LTZ Therapeutics, Inc.
P1
CC
(43)
Ltz-301
Marginal Zone Lymphoma
LTZ Therapeutics, Inc.
P1
CC
(43)
lu-177 labeled 6a10-fab-fragments
Glioblastoma
University Hospital Muenster
P1
CC
(43)
lu 177-psma-3d1015
Castration-Resistant Prostate Carcinoma
Chunjing Yu
P1
CC
(43)
Lu Ag06466
Focal Epilepsy
H. Lundbeck A/S
P1
CC
(43)
Lucar-20Sp Cells
B-Cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute
P1
CC
(43)
Lucar-G39P Cells Product
B-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
Lung Spheroid Stem Cells 200 Million
Idiopathic Pulmonary Fibrosis
University of North Carolina, Chapel Hill
P1
CC
(43)
Lunresertib
Uterine Cancer
University Health Network, Toronto
P1
CC
(43)
Lutetium [177Lu] Bl-Arc001
Digestive System Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
CC
(43)
Lutetium Lu 177 Psma-10.1
Prostate Carcinoma
Emory University
P1
CC
(43)
LXP1788
Renal Cell Carcinoma
LaunXP Biomedical Co., Ltd.
P1
CC
(43)
LXP1788
Neoplasm
LaunXP Biomedical Co., Ltd.
P1
CC
(43)
LXP1788
Refractory Malignant Neoplasm
LaunXP Biomedical Co., Ltd.
P1
CC
(43)
ly007
B-Cell Non-Hodgkin Lymphoma
Ruijin Hospital
P1
CC
(43)
ly03017
Schizophrenia
Luye Pharma Group Ltd.
P1
CC
(43)
LY3143921
Colorectal Cancer
Cancer Research UK
P1
CC
(43)
LY3143921
Ovarian Serous Cystadenocarcinoma
Cancer Research UK
P1
CC
(43)
Showing 2701 to 2725 of 9,922 assets
Previous
Page 109 of 397
Next